Durvalumab vs Hydroxychloroquine

Durvalumab vs Hydroxychloroquine: Overview

This comparison examines the pharmacological differences between Durvalumab and Hydroxychloroquine.

Mechanism of Action

Durvalumab: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.

Hydroxychloroquine: Accumulates in lysosomes raising pH; inhibits toll-like receptor signaling.

Pharmacokinetics

Half-life: Durvalumab — 17 days; Hydroxychloroquine — 40-50 days.

Chemical Properties

Molecular Formula: Hydroxychloroquine — C18H26ClN3O.

Molecular Weight: Hydroxychloroquine — 335.8720 g/mol.

Type: Durvalumab — Antibody; Hydroxychloroquine — Small molecule.